View the official certificates and accreditations of StemCell Longevita's partner laboratory in Istanbul. Our GMP certification, cord blood banking approval, umbilical cord banking license, and stem cell production permits ensure the highest quality and safety standards.
Every patient is treated under a full regulatory and quality stack: our partner laboratory and treatment protocols are Turkish Ministry of Health (MoH) licensed for advanced cellular therapies; Wharton's jelly-derived mesenchymal stem cells are processed under Good Manufacturing Practice (GMP) with documented batch-release criteria and chain-of-custody; the quality management system is certified to ISO 9001; umbilical cord tissue is sourced from consented full-term C-section donations following the international Declaration of Helsinki standards; and all patient data is handled in compliance with Turkey's KVKK (Personal Data Protection Law) and the EU General Data Protection Regulation (GDPR). Each cell batch undergoes cell viability counts, sterility testing, endotoxin screening, mycoplasma testing, and surface-marker identity verification before clinical use.
